Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...

Merck & Co has ended a second phase 3 trial ... Pharma has not given up the hunt for new drugs for Alzheimer’s – despite the setbacks a report by ResearchersAgainstAlzheimer’s last year ...

Weight-loss and diabetes drugs reduced the risk of developing Alzheimer’s, an independent study published Monday showed. The ...

Merck & Co's earlier efforts to find new therapies for Alzheimer's disease resulted in failure, but the company is returning to the field via an R&D alliance with UK biotech Cerevance that will ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

A new study led by Western researchers found frequent treatment with intranasal oxytocin – a hormone in the brain associated ...

Jan. 15, 2025 — Regular aerobic exercise could significantly reduce disease markers associated with Alzheimer's, new research has found. The findings provide new hope in the battle against this ...

Merck CEO Rob Davis told CNBC's Jim Cramer that ... He also pointed to Winrevair, a medicine used to treat a rare and life-threatening lung condition that was approved by the Food and Drug ...